← Back to Search

Caregiver for Pediatric Cancer

N/A
Waitlist Available
Led By Melanie Fields, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of study visit (day 1) for all participants (estimated to be 1 year)
Awards & highlights

Study Summary

This trial aims to use a game-based tool to help caregivers of pediatric oncology patients learn more and worry less.

Eligible Conditions
  • Pediatric Cancer
  • Caregiver Burden

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of study visit (day 1) for all participants (estimated to be 1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of study visit (day 1) for all participants (estimated to be 1 year) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by average time to complete the study visit.
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by percentage of caregivers that enroll and complete study visit.
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by the average time to completion of the educational tool.
Secondary outcome measures
Determine the impact of a game-based tool in decreasing anxiety of caregivers of children newly diagnosed with cancer as measured by change in anxiety.
Determine the impact of a game-based tool in increasing knowledge of caregivers of children newly diagnosed with cancer as measure by change in knowledge.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CaregiverExperimental Treatment1 Intervention
After consent, the study visit will occur. The study visit will consist of a brief set of demographic questions and a pre-game play knowledge assessment and anxiety assessment, followed by completion of the OncoWhiz game. Immediately after utilizing OncoWhiz, the participant will complete a knowledge assessment and anxiety assessment, in addition to a satisfaction survey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OncoWhiz
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,928 Previous Clinical Trials
2,297,058 Total Patients Enrolled
Melanie Fields, M.D.Principal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability for prospective study participants in this clinical trial?

"Unfortunately, as specified on clinicaltrials.gov, this medical trial is not currently accepting patients for enrollment; the listing was initially published on November 15th 2022 and its details have been updated most recently on November 2nd 2022. Nonetheless, 115 other trials are actively in pursuit of new candidates at present."

Answered by AI
~13 spots leftby Mar 2025